Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

FDA Warns of New Blood Cancers With Sarcoma, Lymphoma Drug

FDA Warns of New Blood Cancers With Sarcoma, Lymphoma Drug
ShareXFacebook

(MedPage Today) -- The FDA on Monday alerted clinicians about the risk of new primary hematologic malignancies in patients treated with tazemetostat (Tazverik), a sarcoma and lymphoma drug now being pulled from global markets. The risk was known...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement